Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease

被引：39

作者：

Bhatt, DL ^{[1
]}

Topol, EJ ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2000年 / 84卷 / 01期

关键词：

D O I：

10.1016/S0025-7125(05)70212-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Antiplatelet and anticoagulant medications play a major role in the secondary prevention of ischemic heart disease. Numerous trials have demonstrated their clinical benefits. Newer agents, such as clopidogrel, have challenged aspirin's role as the premier medication for secondary prevention. Much remains to be learned, however, about the merits of these different drug classes, relative to one another and in combination.

引用

页码：163 / +

页数：18

共 96 条

[1] Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial [J].

Al-Khadra, AS ;

Salem, DN ;

Rand, WM ;

Udelson, JE ;

Smith, JJ ;

Konstam, MA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :419-425

[2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[3]

*AM HEART ASS, 1999, AM HEART ASS 1999 ST

[4]

Anand Sonia S., 1999, Journal of the American College of Cardiology, V33, p396A

[5]

[Anonymous], 1988, LANCET, V2, P349

[6]

[Anonymous], 1988, BRIT MED J, V296, P320

[7]

[Anonymous], 1994, Lancet, V343, P499

[8] TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: A double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods [J].

Antman, EM .

AMERICAN HEART JOURNAL, 1998, 135 (06) :S353-S360

[9] Acute coronary syndromes in the GUSTO-IIb trial - Prognostic insights and impact of recurrent ischemia [J].

Armstrong, PW ;

Fu, YL ;

Chang, WC ;

Topol, EJ ;

Granger, CB ;

Betriu, A ;

Van de Werf, F ;

Lee, KL ;

Califf, RM .

CIRCULATION, 1998, 98 (18) :1860-1868

[10] Underutilization of aspirin in older patients with prior myocardial infarction at the time of admission to a nursing home [J].

Aronow, WS .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (05) :615-616

← 1 2 3 4 5 6 7 8 9 10 →